Parkinson Risk Assessment Out of Blood Samples
A new method for diagnosis and prognosis of Parkinson’s disease
Invention: Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease affecting about 2% of the population over 65. The most prominent neuro¬patho¬logical characteristics of PD are progressive cell death within the nigrostriatal system and the appearance of cytoplasmatic aggregates of alpha-synuclein (SNCA), so-called Lewy bodies. The disease is typically diagnosed in an advanced stage when 70% of the dopaminergic neurons are lost. Especially in the light of new disease-modifying treat-ments, there is a great need for the early detection of PD. Scientists of the University of Bonn have found that the methylation pattern of the SNCA-gene is indicative for patients having developed PD. Surprisingly, it could be shown that said methylation status can be assessed based on DNA from peripheral blood cells.
Further Information: PDF
PROvendis GmbH
Phone: +49 (0)208/94105 10
Contact
Dipl.-Ing. Alfred Schillert
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Making diamonds at ambient pressure
Scientists develop novel liquid metal alloy system to synthesize diamond under moderate conditions. Did you know that 99% of synthetic diamonds are currently produced using high-pressure and high-temperature (HPHT) methods?[2]…
Eruption of mega-magnetic star lights up nearby galaxy
Thanks to ESA satellites, an international team including UNIGE researchers has detected a giant eruption coming from a magnetar, an extremely magnetic neutron star. While ESA’s satellite INTEGRAL was observing…
Solving the riddle of the sphingolipids in coronary artery disease
Weill Cornell Medicine investigators have uncovered a way to unleash in blood vessels the protective effects of a type of fat-related molecule known as a sphingolipid, suggesting a promising new…
